| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.06 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |